样式: 排序: IF: - GO 导出 标记为已读
-
Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-16 Daniel Feingold, Dana Tzur Bitan, Marica Ferri, Eva Hoch
-
Association between psychiatric admissions in patients with schizophrenia and IL-6 plasma levels polygenic score Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-16 Fernando Facal, Manuel Arrojo, Mario Páramo, Javier Costas
-
Proinflammatory cytokine levels, cognitive function, and suicidal symptoms of adolescents and young adults with major depressive disorder Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-16 Mu-Hong Chen, Ya-Mei Bai, Ju-Wei Hsu, Kai-Lin Huang, Shih-Jen Tsai
-
Cannabis use and cannabis use disorders and their treatment in the Europe Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-15
Abstract This paper introduces the special issue on cannabis use in Europe. It describes data on the prevalence of cannabis use in Europe and the more limited data on the prevalence of cannabis use disorders, one of the most common forms of drug problem treated in many countries in Europe. It summarises what research has indicated about the adverse effects of acute and chronic cannabis use and discusses
-
Prevalence and associated factors of obesity in patients with major depressive disorder at different ages of onset Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-15 Xiaoen Liu, Xue Tian, Lina Wang, Xiangyang Zhang
Major depressive disorder (MDD) and obesity are two serious public health problems. Although there have been some research on both, there have few studies on differences in obesity among MDD patients at different ages of onset. The study aims to evaluate the prevalence and factors associated with obesity in MDD patients at different ages of onset. This study totally recruited 1718 first-episode drug-naive
-
The impact of the COVID-19 pandemic on perceptions of social relationships, negative affect, and paranoid ideation Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-13 Ryan D. Orth, Christina L. G. Savage, Melanie E. Bennett, Jack J. Blanchard
The COVID-19 pandemic contributed to worsening mental health across the globe. The pandemic may have been especially impactful on those experiencing heightened psychosis spectrum symptomatology given greater pre-pandemic social isolation and increased vulnerability to stress. Yet, few studies exploring the impact of the COVID-19 pandemic on perceptions of social relationships and mental health have
-
Association of empathy with clinical symptoms and cognitive function in chronic schizophrenia patients with and without suicide attempts Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-13 Zheng Ma, Yang Tian, Jiaxin Li, Junyao Liu, Dong-Mei Wang, Xiang-Yang Zhang
Cognitive impairment is recognized as a risk factor for suicide in schizophrenia (SZ) patients. Despite empathy being an important aspect of social cognition, the association between suicidal behavior and empathy has received little attention. We aimed to compare empathy and neurocognition in SZ patients with and without suicide attempts (SAs), and to explore the relationship between empathy, neurocognition
-
Borderline personality disorder vs. schizophrenia spectrum disorders in young people recruited within an “Early Intervention in Psychosis” service: clinical and outcome comparisons Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-12 Lorenzo Pelizza, Emanuela Leuci, Emanuela Quattrone, Silvia Azzali, Giuseppina Paulillo, Simona Pupo, Pietro Pellegrini, Lorenzo Gammino, Arianna Biancalani, Marco Menchetti
-
Correlative relationship between body mass index and heart rate variability in psychiatric disorders Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-12 WenZheng Wang, LinLin Zhou, Qiang Hu, YuQing Gao, YanYan Wei, XiaoChen Tang, YeGang Hu, LiHua Xu, HaiChun Liu, ZiXuan Wang, Tao Chen, ChunBo Li, HaiSu Wu, JiJun Wang, TianHong Zhang
-
The neurobiological effects of childhood maltreatment on brain structure, function, and attachment Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-11 Akemi Tomoda, Shota Nishitani, Shinichiro Takiguchi, Takashi X. Fujisawa, Toshiro Sugiyama, Martin H. Teicher
-
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-10 H. H. Stassen, S. Bachmann, R. Bridler, K. Cattapan, E. Seifritz
-
Demographic, biochemical, clinical, and cognitive symptom differences between smokers and non-smokers in Chinese older male patients with chronic schizophrenia Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-10 Wei Li, Ling Yue, Shifu Xiao
-
Pathways to professional mental care in the Swiss young adult community: a case–control study Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-01 N. Osman, C. Michel, B. G. Schimmelmann, L. Schilbach, E. Meisenzahl, F. Schultze-Lutter
-
The prevalence of poor sleep quality in the general population in China: a meta-analysis of epidemiological studies Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-03-01 Pan Chen, Mei Ieng Lam, Tong Leong Si, Ling Zhang, Lloyd Balbuena, Zhaohui Su, Teris Cheung, Gabor S. Ungvari, Sha Sha, Yu-Tao Xiang
-
White matter brain age as a biomarker of cerebrovascular burden in the ageing brain Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-29
Abstract As the brain ages, it almost invariably accumulates vascular pathology, which differentially affects the cerebral white matter. A rich body of research has investigated the link between vascular risk factors and the brain. One of the less studied questions is that among various modifiable vascular risk factors, which is the most debilitating one for white matter health? A white matter specific
-
Are thoughts and behaviours of individuals with schizophrenia more susceptible to being influenced during pandemic situations? A glimpse provided by the COVID-19 pandemic Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-29
Abstract Individuals with psychotic disorders such as schizophrenia may be more vulnerable during pandemics, but research on this topic is limited. This study examined COVID-19 impact on a population affected by schizophrenia during the COVID-19 pandemic. Levels of psychological distress and COVID-19-related behaviours, from the COVID-related Thoughts and Behavioral Symptoms (Cov-Tabs) Scale, were
-
Dampened motivation in schizophrenia: evidence from a novel effort-based decision-making task in social scenarios Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-28 Yu-Xin Shao, Ling-Ling Wang, Han-Yu Zhou, Zheng-Hui Yi, Shuai Liu, Chao Yan
-
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics? Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-27
Abstract The growing interest in the rapid and sustained antidepressant effects of the dissociative anesthetic ketamine and classic psychedelics, such as psilocybin, is remarkable. However, both ketamine and psychedelics are known to induce acute mystical experiences; ketamine can cause dissociative symptoms such as out-of-body experience, while psychedelics typically bring about hallucinogenic experiences
-
Interactions between overweight/obesity and alcohol dependence impact human brain white matter microstructure: evidence from DTI Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-26
Abstract There is inconsistent evidence for an association of obesity with white matter microstructural alterations. Such inconsistent findings may be related to the cumulative effects of obesity and alcohol dependence. This study aimed to investigate the possible interactions between alcohol dependence and overweight/obesity on white matter microstructure in the human brain. A total of 60 inpatients
-
Neurocognitive function as outcome and predictor for prefrontal transcranial direct current stimulation in major depressive disorder: an analysis from the DepressionDC trial Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-26 Aldo Soldini, Ulrike Vogelmann, Sabine Aust, Stephan Goerigk, Christian Plewnia, Andreas Fallgatter, Claus Normann, Lukas Frase, Peter Zwanzger, Thomas Kammer, Carlos Schönfeldt-Lecuona, Gizem Vural, Malek Bajbouj, Frank Padberg, Gerrit Burkhardt
-
Hypothalamic subunit volumes and relations to violence and psychopathy in male offenders with or without a psychotic disorder Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-14 Christina Bell, Jaroslav Rokicki, Natalia Tesli, Tiril P. Gurholt, Gabriela Hjell, Thomas Fischer-Vieler, Nina Bang, Ingrid Melle, Ingrid Agartz, Ole A. Andreassen, Petter Andreas Ringen, Kirsten Rasmussen, Hilde Dahl, Christine Friestad, Unn K. Haukvik
-
Long-term follow-up of brain regional changes and the association with cognitive impairment in quarantined COVID-19 survivors Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-06 Simai Zhang, Minlan Yuan, Danmei He, Wen Dang, Wei Zhang
-
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-06 Barbara Morgado, Hans-Wolfgang Klafki, Chris Bauer, Katharina Waniek, Hermann Esselmann, Oliver Wirths, Niels Hansen, Ingolf Lachmann, Dirk Osterloh, Johannes Schuchhardt, Jens Wiltfang
-
Identifying novel chemical-related susceptibility genes for five psychiatric disorders through integrating genome-wide association study and tissue-specific 3′aQTL annotation datasets Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-02-02 Sirong Shi, Huijie Zhang, Xiaoge Chu, Qingqing Cai, Dan He, Xiaoyue Qin, Wenming Wei, Na Zhang, Yijing Zhao, Yumeng Jia, Feng Zhang, Yan Wen
-
How personality functioning relates to psychological distress and behavioral attitudes during the Covid-19 pandemic Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-01-06
Abstract Functional aspects of personality are crucial for experiencing and handling emotional distress. With the outbreak of the Covid-19 virus and the subsequent installation of mitigation rules of social distancing, severe psycho-social challenges were posed upon people. Research has shown that individuals react differently to these challenges. This study aimed to investigate the role of dimensional
-
Conceptual foundations of acetylcarnitine supplementation in neuropsychiatric long COVID syndrome: a narrative review Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-01-03 Dario Lucas Helbing, Eva-Maria Dommaschk, Lena Vera Danyeli, Edgars Liepinsh, Alexander Refisch, Zümrüt Duygu Sen, Liga Zvejniece, Tonia Rocktäschel, Leonie Karoline Stabenow, Helgi B. Schiöth, Martin Walter, Maija Dambrova, Bianca Besteher
-
Vaccination and clozapine use: a systematic review and an analysis of the VAERS database Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2024-01-02 Aslihan Aksar, Justina Lutz, Elias Wagner, Wolfgang Strube, Jurjen J. Luykx, Alkomiet Hasan
-
Grouping motivational interviewing is only effective for younger patients with alcohol dependence in the rehabilitation stage Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-20 Jing Yao, Kun Han, Hongmei Cui, Nan Chen, Meihong Xiu, Fengchun Wu
-
Linking social motivation, general motivation, and social cognition to interpersonal functioning in schizophrenia: insights from exploratory graph analysis Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-19
Abstract Motivation in general, and social motivation in particular are important for interpersonal functioning in individuals with schizophrenia. Still, their roles after accounting for social cognition, are not well understood. The sample consisted of 147 patients with schizophrenia. General motivation was measured using the Behavioral inhibition/activation scale (BIS/BAS). Social motivation was
-
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-19 Francesca Martini, Marco Spangaro, Margherita Bechi, Giulia Agostoni, Mariachiara Buonocore, Jacopo Sapienza, Daniela Nocera, Chiara Ave, Federica Cocchi, Roberto Cavallaro, Marta Bosia
-
The correlation of Esketamine with specific adverse events: a deep dive into the FAERS database Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-16 Ying Jiang, Zhiqiang Du, Yuan Shen, Qin Zhou, Haohao Zhu
Analyzing the vast data from FAERS database to evaluate the association between Esketamine and specific adverse events to guide clinical practice and regulatory decisions. Data related to Esketamine adverse events from 2019 Q1 to 2023 Q1 were collected from FAERS database. After data standardization, various signal quantification technologies, such as ROR, PRR, BCPNN, and MGPS, were employed to identify
-
LD block disorder-specific pleiotropic roles of novel CRHR1 in type 2 diabetes and depression disorder comorbidity Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-14 Laura del Bosque-Plata, Mutaz Amin, Ricardo González-Ramírez, Rongling Wu, Teodor T. Postolache, Michael Vergare, Derek Gordon, Claudia Gragnoli
-
Non-standard diagnostic assessment reliability in psychiatry: a study in a Brazilian outpatient setting using Kappa Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-12 Helio G. Rocha Neto, José Luiz Martins Lessa, Luisa Mendez Koiller, Amanda Machado Pereira, Bianca Marques de Souza Gomes, Carlos Linhares Veloso Filho, Carlos Henrique Casado Telleria, Maria T. Cavalcanti, Diogo Telles-Correia
-
Effects of antipsychotic drugs on energy metabolism Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-10 Bruna Panizzutti, Chiara C. Bortolasci, Briana Spolding, Srisaiyini Kidnapillai, Timothy Connor, Sheree D. Martin, Trang T. T. Truong, Zoe S. J. Liu, Laura Gray, Greg M. Kowalski, Sean L. McGee, Jee Hyun Kim, Michael Berk, Ken Walder
-
A clinical approach to the investigation and management of long COVID associated neuropathic pain Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-08 Rajish Sanjit Kumar Shil, Thomas William Hughes, Brendan Francis Sargent, Yun Huang, Arina Anna Tamborska, Bernhard Frank, Mark Alexander Ellul, Benedict Daniel Michael
-
Self-reported interoception and exteroception are atypical and excessively coupled in psychosis compared to healthy controls Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-10 Stefano Damiani, Andrea Silva, Alberto Donadeo, Marie Emilie Giovannelli, Fabrizio Pavone, Elena Farinella, Matteo Rocchetti, Pierluigi Politi, Paolo Fusar-Poli
-
Parental marital status and anxiety symptoms in adolescents: the mediating effect of childhood maltreatment Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-07 Lulu Wen, Kun Yang, Yujia Cao, Miao Qu, Meihong Xiu
-
Global reward processing deficits predict negative symptoms transdiagnostically and transphasically in a severe mental illness-spectrum sample Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-05 Lauren Luther, Sierra A. Jarvis, Michael J. Spilka, Gregory P. Strauss
-
Effects of melancholic features on positive and negative suicidal ideation in patients with treatment-resistant depression and strong suicidal ideation receiving low-dose ketamine infusion Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-05 Mu-Hong Chen, Tung-Ping Su, Cheng-Ta Li, Wei-Chen Lin, Hui-Ju Wu, Shih-Jen Tsai, Ya-Mei Bai, Wei-Chung Mao, Pei-Chi Tu
-
Network structure of symptomatology of adult attention-deficit hyperactivity disorder in patients with mood disorders Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-06 Jakyung Lee, Daseul Lee, HongKyu Ihm, Hyo Shin Kang, Hyeona Yu, Joohyun Yoon, Yoonjeong Jang, Yuna Kim, Chan Woo Lee, Hyukjun Lee, Ji Hyun Baek, Tae Hyon Ha, Jungkyu Park, Woojae Myung
-
Exploring specific associations of childhood maltreatment with social cognition in drug-naive first-episode major depressive disorder: a sex-centric approach Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-01 Yuan Liu, Chuhao Zhang, Meijuan Li, Ying Gao, Yuting Wang, Xueying Liu, Jie Li
-
All eyes on PCS: analysis of the retinal microvasculature in patients with post-COVID syndrome—study protocol of a 1 year prospective case–control study Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-12-02 Timon Kuchler, Renate Hausinger, Matthias C. Braunisch, Roman Günthner, Rebecca Wicklein, Benjamin Knier, Nathalie Bleidißel, Matthias Maier, Andrea Ribero, Maciej Lech, Kristina Adorjan, Hans Stubbe, Konstantin Kotilar, Uwe Heemann, Christoph Schmaderer
-
Clinical predictors of suicidal ideation, suicide attempts and suicide death in depressive disorder: a systematic review and meta-analysis Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-28 Pau Riera-Serra, Guillem Navarra-Ventura, Adoración Castro, Margalida Gili, Angie Salazar-Cedillo, Ignacio Ricci-Cabello, Lorenzo Roldán-Espínola, Victoria Coronado-Simsic, Mauro García-Toro, Rocío Gómez-Juanes, Miquel Roca
-
Shared Decision Making Assistant (SDMA) and other digital tools for choosing antipsychotics in schizophrenia treatment Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-29 Stefan Leucht, Spyridon Siafis, Alessandro Rodolico, Natalie L. Peter, Katharina Müller, Jakob Waibel, Wolfgang Strube, Alkomiet Hasan, Ingrid Bauer, Peter Brieger, John M. Davis, Johannes Hamann
-
Prevalence and influencing factors of sleep disturbance among medical students under the COVID-19 pandemic Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-26 Shuo Wang, Guoshuai Luo, Xue Zhang, Yifan Jing, Zaimina, Cong Yao, Meijuan Li, Hongli Chen, Jie Li
-
Effect modification of tumor necrosis factor-α on the kynurenine and serotonin pathways in major depressive disorder on type 2 diabetes mellitus Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-22 Naomichi Okamoto, Takashi Hoshikawa, Yuichi Honma, Enkhmurun Chibaatar, Atsuko Ikenouchi, Masaru Harada, Reiji Yoshimura
-
The common misconception of blood–brain barrier terminology in psychiatry and neurology Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-23 Vladislav Yakimov, Joanna Moussiopoulou, Alkomiet Hasan, Elias Wagner
-
Changes in neuroactive steroids, neurotrophins and immunological biomarkers after monotherapy 8-week rTMS treatment and their relationship with neurocognitive functions in depression Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-18 Muhammed Emin Boylu, Şenol Turan, Eray Metin Güler, Fatma Betül Boylu, Özge Kılıç, Abdurrahim Koçyiğit, İsmet Kırpınar
-
Personality disorders: the impact of severity on societal costs Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-22 Carl-Aksel Sveen, Geir Pedersen, Benjamin Hummelen, Elfrida Hartveit Kvarstein
Personality disorders (PDs) are associated with high levels of societal costs. However, previous research has found limited or no evidence of unique contributions of individual PD categories on the overall level of societal costs. Recent research supports the validity of PD as a dimensional construct, and PD severity may be a better predictor of societal costs than specific PD categories. The aim of
-
Neural mechanisms underlying attentional bias modification in fibromyalgia patients: a double-blind ERP study Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-19 Roberto Fernandes-Magalhaes, Alberto Carpio, David Ferrera, Irene Peláez, María Eugenia De Lahoz, Dimitri Van Ryckeghem, Stefaan Van Damme, Francisco Mercado
-
Differential neurocognitive profiles in adult attention-deficit/hyperactivity disorder subtypes revealed by the Cambridge Neuropsychological Test Automated Battery Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-18 Szilvia Somogyi, Tünde Kilencz, Katalin Szőcs, Izabella Klein, Lívia Balogh, Rebeka Molnár, Sára Bálint, Attila J. Pulay, Zsófia Nemoda, Máté Baradits, János M. Réthelyi
-
Association of P50 with social function, but not with cognition in patients with first-episode schizophrenia Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-15 Dongmei Wang, Luyao Xia, Zhiqi Zhang, Junru Guo, Yang Tian, Huixia Zhou, Meihong Xiu, Dachun Chen, Xiang-Yang Zhang
-
Transcranial direct current stimulation combined with a brief intervention for smoking cessation: a randomized double-blind clinical trial Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-13 Ulrich Palm, Mark Obergfell, Andrea Rabenstein, Jonas Björklund, Gabi Koller, Frank Padberg, Tobias Rüther
-
Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implications Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-13 Michael Ruzicka, Gerardo Jesus Ibarra Fonseca, Simone Sachenbacher, Fides Heimkes, Fabienne Grosse-Wentrup, Nora Wunderlich, Christopher Benesch, Anna Pernpruner, Elisabeth Valdinoci, Mike Rueb, Aline Olivia Uebleis, Susanne Karch, Johannes Bogner, Julia Mayerle, Michael von Bergwelt-Baildon, Marion Subklewe, Bernhard Heindl, Hans Christian Stubbe, Kristina Adorjan
-
Cortical excitation/inhibition ratios in patients with major depression treated with electroconvulsive therapy: an EEG analysis Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-10 Sven Stuiver, Julia C. M. Pottkämper, Joey P. A. J. Verdijk, Freek ten Doesschate, Eva Aalbregt, Michel J. A. M. van Putten, Jeannette Hofmeijer, Jeroen A. van Waarde
-
Positive association between increased homocysteine and deficit syndrome in Chinese patients with chronic schizophrenia: a large-scale cross-sectional study Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-09 Pu Peng, Dongmei Wang, Qianjin Wang, Yanan Zhou, Yuzhu Hao, Shubao Chen, Qiuxia Wu, Tieqiao Liu, Xiangyang Zhang
-
Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesions Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-11-07 Ana-Maria Iorgu, Andrei-Nicolae Vasilescu, Natascha Pfeiffer, Rainer Spanagel, Anne Stephanie Mallien, Dragos Inta, Peter Gass
-
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-10-28 Núria Guillén, José Contador, Mariateresa Buongiorno, Ignacio Álvarez, Natalia Culell, Daniel Alcolea, Alberto Lleó, Juan Fortea, Gerard Piñol-Ripoll, Anna Carnes-Vendrell, María Lourdes Ispierto, Dolores Vilas, Albert Puig-Pijoan, Aida Fernández-Lebrero, Mircea Balasa, Raquel Sánchez-Valle, Albert Lladó
Core Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers have shown incomplete agreement with amyloid-positron emission tomography (PET). Our goal was to analyze the agreement between AD CSF biomarkers and amyloid-PET in a multicenter study. Retrospective multicenter study (5 centers). Participants who underwent both CSF biomarkers and amyloid-PET scan within 18 months were included. Clinical
-
The relationship between inflammatory markers, clinical characteristics, and cognitive performance in drug-naïve patients with schizophrenia Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-10-30 Xiaoxiao Sun, Guoshuai Luo, Xue Li, Jiayue Wang, Yuying Qiu, Meijuan Li, Jie Li
-
Prevalence and risk factors of suicide attempts in young, first-episode and drug-naïve Chinese Han outpatients with psychotic major depressive disorder Eur. Arch. Psychia. Clin. Neurosci. (IF 4.7) Pub Date : 2023-10-25 ZhaoXuan Shang, XiaoE Lang, Jikun Wang, XiangYang Zhang